Skip to main content
Toggle navigation
Login
Search
Home
Tweets by 2023 National Biotechnology Conference
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet this
Print
William Martin (he/him/his)
COO/CIO
EpiVax Inc.
Poster(s):
(M1030-01-04) Comprehensive Assessment of Immunogenicity Risk of Host Cell Proteins in Biologics Using In Silico and In Vitro Methods
Monday, April 24, 2023
10:30 AM – 11:30 AM
ET
(M1130-01-05) Multi-factored Immunogenicity Risk Assessment Approach for Bispecific Immune Cell Engagers
Monday, April 24, 2023
11:30 AM – 12:30 PM
ET
